From the Journals

Diets Higher in Ultra-Processed Foods Raise Risk for Rheumatoid Arthritis


 

TOPLINE:

Middle-aged adults who consume more ultra-processed foods have an elevated risk for rheumatoid arthritis (RA) that is mediated in part through circulating biomarkers.

METHODOLOGY:

  • Investigators conducted a retrospective cohort study of 207,012 middle-aged adults without RA from the UK Biobank who completed 24-hour dietary recalls.
  • Foods and beverages were classified as (1) unprocessed or minimally processed foods, (2) processed culinary ingredients, (3) processed foods, or (4) ultra-processed foods (eg, soft drinks, sweet or savory packaged snacks, reconstituted meat products, pre-prepared frozen dishes).
  • The main outcome was the incident RA based on hospital diagnoses.

TAKEAWAY:

  • Overall, 0.9% of participants received an RA diagnosis during a median follow-up of about 12 years.
  • Relative to peers in the lowest quintile of ultra-processed food consumption, participants in the highest quintile had a 17% greater adjusted risk for RA.
  • The risk rose across quintile (P < .05) and increased by 6% with each standard deviation increase in ultra-processed food intake.
  • Mediation analyses suggested that inflammatory, lipid, and liver enzyme biomarkers explained 3.1%-14.8% of the association between ultra-processed food intake and RA risk.
  • Findings were similar regardless of participants’ age, sex, body mass index, smoking status, household income, and healthy diet score.

IN PRACTICE:

“Lower [ultra-processed food] consumption is recommended to reduce RA incidence,” the authors wrote, noting that up to half of the food consumed in the United Kingdom now falls into the ultra-processed category. “Dietary guidelines should prominently feature the detrimental effects of [ultra-processed foods], and recommendations to curtail their consumption should be integrated into public health initiatives, to mitigate the risk of RA,” they added.

SOURCE:

The study was led by Haodong Zhao, Soochow University, Suzhou, China, and was published online in The American Journal of Clinical Nutrition.

LIMITATIONS:

Limitations included possible recall and social desirability biases, potential residual confounding, and uncertain causality of the observed associations.

DISCLOSURES:

The study was funded by grants from the National Natural Science Foundation of China and other institutions. The authors reported no conflicts of interest.

A version of this article first appeared on Medscape.com.

Recommended Reading

US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives
MDedge Rheumatology
Rheumatoid Arthritis May Raise Lung Cancer Risk, Particularly in Those With ILD
MDedge Rheumatology
Do You Have Patients With JAKne — JAK Inhibitor–Associated Acne? Here’s What to Know
MDedge Rheumatology
Mobile App Shows Promise in Managing Fibromyalgia Symptoms
MDedge Rheumatology
Patients With Immune-Mediated Inflammatory Diseases, Type 2 Diabetes Reap GLP-1 Receptor Agonist Benefits, Too
MDedge Rheumatology
After Remission Failure in Early RA, Adding Etanercept No Better Than Adding Leflunomide
MDedge Rheumatology
We Asked 7 Doctors: How Do You Get Patients to Exercise?
MDedge Rheumatology
Teclistamab Promising as a Treatment of Last Resort for Refractory Autoimmune Diseases
MDedge Rheumatology
Stroke Risk from Atrial Fibrillation Rises in Presence of Rheumatoid Arthritis
MDedge Rheumatology
Kidney Disease May Accelerate With Higher Rheumatoid Arthritis Disease Activity
MDedge Rheumatology